Building back cancer services in England.
by Patel, Parth; Thomas, Chris.Institute for Public Policy Research.
Publisher: IPPR, London : 2021.Description: 16p.General Note: This research was produced together with CF (a health consultancy and data analytics company). .Summary: This research finds that even if stretched hospitals can maintain activity levels five per cent above pre-pandemic levels, it will still take until 2033 to clear the cancer treatment ‘missing patients backlog’ caused by the pandemic. However, if activity levels can be increased further and maintained at 15 per cent above pre-pandemic levels, backlogs across the cancer care pathway could be cleared by next year. However this uplift in cancer care activity could only be achieved with new policy to increase the cancer workforce and investment in diagnostic equipment beyond the new funding announced in September 2021..Subject(s): cancer services | service demand | access to health services | Covid-19 | pandemics | statistical data | financing | workforce | clinical diagnosis | EnglandDigital copyAvailability: Online access List(s) this item appears in: Covid-19: health and social care recovery in England [January 2023]
| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Web publication | The King's Fund Library Online resource | Web publications and sites | Web publications (Browse shelf(Opens below)) | Not for loan |
This research was produced together with CF (a health consultancy and data analytics company).
This research finds that even if stretched hospitals can maintain activity levels five per cent above pre-pandemic levels, it will still take until 2033 to clear the cancer treatment ‘missing patients backlog’ caused by the pandemic. However, if activity levels can be increased further and maintained at 15 per cent above pre-pandemic levels, backlogs across the cancer care pathway could be cleared by next year. However this uplift in cancer care activity could only be achieved with new policy to increase the cancer workforce and investment in diagnostic equipment beyond the new funding announced in September 2021.
There are no comments on this title.